demonstrated that mutant SETBP1 enhances activation of the mitogen-activated protein kinase 1 (MAPK) pathway by the proto-oncogene GTPase NRAS, promoting aggressive leukemia (19). The gene discussed is NRAS; the disease is leukemia.